Plasma alpha fetoprotein (AFP), one of the most frequently used biomarkers for diagnosis of hepatocellular carcinoma (HCC)1, has been described by many as a marker with low sensitivity and/or specificity2–5. Here, AFP is linked to hepatocellular carcinoma.